Reagents required for provider/patient management of outpatient care and referral site. Failure to acquire these reagents would results in a total work stoppage.
Ended Awarded
- Contract number
- HT009025FG0930033
- Awardee
-
Roche Diagnostics Corporation UEI JDMDFEZBYH36
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $107,365
Award facts
- Contract value 100% obligated
- $107,364.70 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- Set-aside
- No set-aside
- Competition
- Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Castleton, IN 46256, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Health Agency awarded a BPA Call contract to Roche Diagnostics Corporation on August 21, 2025, with a ceiling value of $107,364.70 and an ultimate completion date of September 30, 2025. This firm fixed-price contract, with no set-aside designation, procures reagents essential for provider and patient management in outpatient care and referral site operations. The government description emphasizes the critical nature of these reagents, noting that failure to acquire them would result in total work stoppage. The contract will be performed at the vendor's location in Castleton, Indiana.
Roche Diagnostics Corporation, a foreign-owned manufacturer of in vitro diagnostics and laboratory equipment, is a global leader in diagnostic solutions serving military, veterans, and civilian healthcare systems. This contract represents a call against an existing Blanket Purchase Agreement, likely established under GSA Schedule contracts such as the In Vitro Diagnostics, Reagents, Test schedule. As a child contract under a larger vehicle, it enables the Defense Health Agency to efficiently procure Roche's pre-negotiated diagnostic reagents and related products through established terms and pricing. Roche's extensive portfolio of federal contracts demonstrates its significant role in supporting laboratory testing services, molecular diagnostics, and clinical testing across federal healthcare agencies.
Quick answers
Who was awarded contract HT009025FG0930033?
HT009025FG0930033 was awarded to Roche Diagnostics Corporation by Defense Health Agency (Department of Defense) on August 21, 2025.
How much is contract HT009025FG0930033 worth?
The government has obligated $107,365 on HT009025FG0930033.
Is contract HT009025FG0930033 an order under another contract?
Yes. HT009025FG0930033 is a BPA call under FA301625A0005, a blanket purchase agreement.
Was contract HT009025FG0930033 competed?
The extent of competition for HT009025FG0930033 was competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award